Thursday, December 1, 2016

REFILE-UPDATE 1-Aradigm's inhaled antibiotic fails late-stage study, shares sink

Dec 1 (Reuters) - Aradigm Corp said on Thursday its

inhaled antibiotic for a rare, incurable disorder affecting the

lungs failed in a late-stage study, sending the company's shares

down nearly 54...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)